Mahana Therapeutics, a developer of FDA-cleared app-based, digital prescription digital therapeutics treatments for irritable bowel syndrome (IBS), completed a $61 million Series B financing. JAZZ
![Mahana Therapeutics Raises $61 Million for Digital Therapeutics App](https://mercomcapital.com/wp-content/uploads/2020/04/Mercom-7.png)
Mahana Therapeutics, a developer of FDA-cleared app-based, digital prescription digital therapeutics treatments for irritable bowel syndrome (IBS), completed a $61 million Series B financing. JAZZ